IGC Pharma | 0.3003 -0.0358 -10.65% | ||
| IGC | |||
| 高 0.3400 | 开 0.3379 | 量 283.91万股 | 总市值 2788.83万 |
| 低 0.2956 | 换 3.06% | 额 89.82万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
IGC Pharma(IGC)
12-16 05:05
$IGC Pharma(IGC)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001185185-25-002055 Act: 34 Size: 680 KB 网页链接
IGC Pharma(IGC)
12-08 19:25
$IGC Pharma(IGC)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003555 Act: 33 Size: 1 KB 网页链接
IGC Pharma(IGC)
12-04 05:15
$IGC Pharma(IGC)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001185185-25-001914 Act: 33 Size: 176 KB 网页链接
IGC Pharma(IGC)
11-17 19:05
$IGC Pharma(IGC)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001185185-25-001759 Act: 33 Size: 315 KB 网页链接
IGC Pharma(IGC)
11-15 06:35
$IGC Pharma(IGC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001185185-25-001757 Act: 33 Size: 452 KB 网页链接
IGC Pharma(IGC)
11-15 05:25
$IGC Pharma(IGC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001185185-25-001752 Act: 34 Size: 5 MB 网页链接
IGC Pharma(IGC)
11-14 23:05
$IGC Pharma(IGC)$ 8-K Current report, items 2.01 and 9.01 Accession Number: 0001185185-25-001713 Act: 34 Size: 284 KB 网页链接
IGC Pharma(IGC)
10-22 20:35
$IGC Pharma(IGC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001520 Size: 5 KB 网页链接
IGC Pharma(IGC)
10-21 20:55
$IGC Pharma(IGC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001506 Size: 5 KB 网页链接
IGC Pharma(IGC)
10-21 20:55
$IGC Pharma(IGC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001508 Size: 5 KB 网页链接
IGC Pharma(IGC)
10-21 20:45
$IGC Pharma(IGC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001504 Size: 9 KB 网页链接
IGC Pharma(IGC)
10-21 08:15
$IGC Pharma(IGC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001185185-25-001500 Size: 9 KB 网页链接
IGC Pharma(IGC)
10-14 18:05
$IGC Pharma(IGC)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001185185-25-001428 Act: 34 Size: 258 KB 网页链接
IGC Pharma(IGC)
10-02 04:45
$IGC Pharma(IGC)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001185185-25-001326 Act: 34 Size: 250 KB 网页链接
IGC Pharma(IGC)
09-20 04:05
$IGC Pharma(IGC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001185185-25-001235 Act: 33 Size: 306 KB 网页链接
IGC Pharma(IGC)
08-19 18:05
$IGC Pharma(IGC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001185185-25-001023 Act: 34 Size: 131 KB 网页链接
IGC Pharma(IGC)
08-19 03:05
$IGC Pharma(IGC)$ DEF 14A Other definitive proxy statements Accession Number: 0001185185-25-001021 Act: 34 Size: 1 MB 网页链接
IGC Pharma(IGC)
08-15 04:15
$IGC Pharma(IGC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001185185-25-000997 Act: 34 Size: 9 MB 网页链接
IGC Pharma(IGC)
08-04 18:15
$IGC Pharma(IGC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001185185-25-000890 Act: 34 Size: 1 MB 网页链接
IGC Pharma(IGC)
07-29 18:15
$IGC Pharma(IGC)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002377 Act: 33 Size: 1 KB 网页链接